Document 0375
 DOCN  M9460375
 TI    AIDS risk reduction and reduced HIV seroconversion among injection drug
       users in Bangkok [see comments]
 DT    9404
 AU    Des Jarlais DC; Choopanya K; Vanichseni S; Plangsringarm K; Sonchai W;
       Carballo M; Friedmann P; Friedman SR; Beth Israel Medical Center, New
       York, NY.
 SO    Am J Public Health. 1994 Mar;84(3):452-5. Unique Identifier : AIDSLINE
       MED/94175192
 CM    Comment in: Am J Public Health 1994 Mar;84(3):350
 AB    Human immunodeficiency virus (HIV) seroconversion was studied in a group
       of 173 injection drug users in Bangkok, Thailand, who had been
       previously tested for HIV and were interviewed and retested in the fall
       of 1989. Ten percent of the group had seroconverted. Two factors
       protected against HIV seroconversion: having stopped sharing injection
       equipment in response to the acquired immunodeficiency syndrome (AIDS)
       and having a regular sexual partner. The association between
       self-reported deliberate risk reduction and reduced HIV seroconversion
       among persons continuing to inject illicit drugs indicates that
       injection drug users can change their behavior in response to AIDS and
       will accurately report on the behavior change, and that the changes can
       protect against HIV infection.
 DE    Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL/  PSYCHOLOGY
       Female  Health Education  Human  HIV Seropositivity/*PSYCHOLOGY
       Logistic Models  Male  Needle Sharing  *Risk-Taking  Sex Behavior
       Sexual Partners  Substance Abuse, Intravenous/*PSYCHOLOGY  Support,
       Non-U.S. Gov't  Support, U.S. Gov't, P.H.S.  Thailand  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).